piracetam has been researched along with kainic acid in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Adamo, EB; Altavilla, D; Calabresi, P; Campo, GM; Costa, C; Esposito, M; Ientile, R; Marini, H; Marini, R; Minutoli, L; Passaniti, M; Pisani, F; Squadrito, F | 1 |
| Albo, F; Carunchio, I; Ciotti, MT; Pieri, M; Zona, C | 1 |
| Dassesse, D; Gillard, M; Hanon, E; Kaminski, RM; Klitgaard, H; Leclercq, K; Lorent, G; Matagne, A | 1 |
| Kato, N; Kudo, K; Maru, E; Shibasaki, T; Sugaya, Y | 1 |
| Chang, M; Fitzgerald, E; Folkerth, RD; Jensen, FE; Kosaras, B; Murphy, A; Talos, DM | 1 |
| Bankstahl, M; Klein, S; Löscher, W | 1 |
| Chen, YH; Chiang, YH; Chou, YC; Hoffer, BJ; Huang, EY; Kuo, TT; Ma, HI; Tsai, JJ; Wu, PJ | 1 |
| Cincioğlu-Palabiyik, M; Ertoy-Baydar, D; Karahan, H; Kelicen-Uğur, P; Sara, Y; Üner, M | 1 |
| Kandeda, AK; Mabou, ST; Nodeina, S | 1 |
10 other study(ies) available for piracetam and kainic acid
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Levetiracetam protects against kainic acid-induced toxicity.
Topics: Animals; Behavior, Animal; Brain; Cells, Cultured; Cerebral Cortex; Diencephalon; DNA Primers; Excitatory Amino Acid Agonists; Glutathione; Inflammation; Interleukin-1; Kainic Acid; Levetiracetam; Lipid Peroxidation; Macrophages; Male; Malondialdehyde; Neurons; Neurotoxicity Syndromes; Nootropic Agents; Piracetam; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA | 2004 |
Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam.
Topics: Action Potentials; Animals; Anticonvulsants; Cells, Cultured; Cerebral Cortex; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Kainic Acid; Levetiracetam; Mice; Neurons; Patch-Clamp Techniques; Piracetam; Receptors, AMPA; Receptors, Kainic Acid | 2007 |
Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.
Topics: Amygdala; Animals; Anticonvulsants; Binding Sites; Brain; Disease Models, Animal; Electroshock; Epilepsy; Kainic Acid; Kindling, Neurologic; Levetiracetam; Male; Membrane Glycoproteins; Mice; Mice, Knockout; Nerve Tissue Proteins; Pentylenetetrazole; Pharmacogenetics; Phenotype; Piracetam | 2009 |
Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus.
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Dentate Gyrus; Disease Models, Animal; Electroencephalography; Homeodomain Proteins; Immunohistochemistry; Kainic Acid; Levetiracetam; Neurons; Nootropic Agents; Piracetam; Rats; Seizures; Status Epilepticus; Tetanus Toxin; Time Factors; Tumor Suppressor Proteins | 2010 |
Antiepileptic effects of levetiracetam in a rodent neonatal seizure model.
Topics: Animals; Animals, Newborn; Anticonvulsants; Blotting, Western; Brain; Immunohistochemistry; Kainic Acid; Levetiracetam; Membrane Glycoproteins; Nerve Tissue Proteins; Piracetam; Rats; Seizures | 2013 |
Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
Topics: Animals; Anticonvulsants; Carbamazepine; Diazepam; Disease Models, Animal; Drug Resistance; Electrodes, Implanted; Electroencephalography; Epilepsy, Temporal Lobe; Female; Hippocampus; Kainic Acid; Levetiracetam; Mice; Phenobarbital; Phenytoin; Piracetam; Seizures; Valproic Acid | 2015 |
Levetiracetam prophylaxis ameliorates seizure epileptogenesis after fluid percussion injury.
Topics: Animals; Anticonvulsants; Brain Injuries, Traumatic; CA1 Region, Hippocampal; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy, Post-Traumatic; Kainic Acid; Levetiracetam; Male; Neurons; Neuroprotective Agents; Piracetam; Rats, Sprague-Dawley; Seizures; Severity of Illness Index; Time Factors | 2016 |
Chronic levetiracetam decreases hippocampal and testicular aromatase expression in normal but not kainic acid-induced experimental model of acute seizures in rats.
Topics: Animals; Aromatase; Cerebral Cortex; Epididymis; Hippocampus; Kainic Acid; Levetiracetam; Male; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Piracetam; Rats, Wistar; Seizures; Testis; Time Factors; Vas Deferens | 2017 |
An aqueous extract of Syzygium cumini protects against kainate-induced status epilepticus and amnesia: evidence for antioxidant and anti-inflammatory intervention.
Topics: Amnesia; Animals; Anti-Inflammatory Agents; Anticonvulsants; Antioxidants; Kainic Acid; Mice; Piracetam; Plant Extracts; Status Epilepticus; Syzygium; Valproic Acid | 2022 |